 |
Non Steroidal Anti Inflammatory Drugs - Special Authority Criteria
| Generic Name / Strength / Form |
| diclofenac - regular release forms |
| Criteria |
Approval Period |
| 1. Diagnosis of rheumatoid or psoriatic arthritis or ankylosing spondylitis or gout or lupus.
OR
2. Treatment failure or intolerance to at least one of the following: ASA-enteric, naproxen, or ibuprofen. |
Indefinite |
Practitioner Exemptions
Special Notes
- Group 2 NSAID
- Coverage for diclofenac 75mg and 100mg sustained release products are subject to further limitations. Full coverage is only provided for individuals who have documented breakthrough symptoms while on the regular release form for a trial period. Full coverage is not provided for dosage convenience.
- Topical diclofenac is not eligible for Pharmacare coverage.
- Suppositories are regular benefits and not subject to the RDP.
Online Form (PDF)
Click on the link to complete a special authority request form.
PDF Format
Some documents on this Web site are in PDF format and require a PDF reader. If you do not have Adobe Acrobat Reader Version 7.0 or the most recent version of another PDF reader, you can download Adobe Acrobat Reader by selecting the 'Get Acrobat Reader' icon.
Last Revised: June 21, 2006
|
